Dr. Reddy’s strengthens on entering into branded consumer health arena

25 May 2016 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 3055.00, up by 29.75 points or 0.98% from its previous closing of Rs. 3025.25 on the BSE.

The scrip opened at Rs. 3030.00 and has touched a high and low of Rs. 3075.00 and Rs. 3019.50 respectively. So far 25,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3075.00 and Rs. 3014.00 respectively. The current market cap of the company is Rs. 52,099.85 crore.

The promoters holding in the company stood at 25.58% while Institutions and Non-Institutions held 42.02% and 15.65% respectively.

Dr. Reddy’s Laboratories has entered into the branded consumer health arena through the acquisition of six over-the-counter (OTC) brands from Ducere Pharma, including Doan’s, Bufferins, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.

These legacy products enjoy strong brand equity built over several decades. The company is extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1168.75 -6.80 (-0.58%)
19-Jan-2026 09:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1651.85
Dr. Reddys Lab 1168.75
Cipla 1384.65
Zydus Lifesciences 862.40
Lupin 2150.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×